We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
+9.54%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$99.2B
AUM Growth
+$5.03B
(+5.3%)
Cap. Flow
-$3.09B
Cap. Flow
% of AUM
-3.12%
Top 10 Holdings %
Top 10 Hldgs %
19.66%
Holding
3,988
New
43
Increased
2,065
Reduced
941
Closed
658
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$283M |
| 2 |
Microsoft
MSFT
|
+$139M |
| 3 |
UBS Group
UBS
|
+$131M |
| 4 |
Mercado Libre
MELI
|
+$96.4M |
| 5 |
Alcon
ALC
|
+$66.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$309M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$230M |
| 3 |
Apple
AAPL
|
+$226M |
| 4 |
Alibaba
BABA
|
+$225M |
| 5 |
Morgan Stanley
MS
|
+$214M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.84% |
| 2 | Healthcare | 15.57% |
| 3 | Financials | 13.55% |
| 4 | Consumer Discretionary | 9.29% |
| 5 | Industrials | 8.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CBAY
2576
DELISTED
Cymabay Therapeutics
CBAY
| $573K | ﹤0.01% |
+65,746
| New | +$526K |
|
2577
N-able
NABL
$940M
| $573K | ﹤0.01% |
43,388
+10
| +0% | +$111 |
|
|
SRDX
2578
DELISTED
Surmodics
SRDX
| $573K | ﹤0.01% |
25,136
+1,419
| +6% | +$36.5K |
|
2579
Compass
COMP
$9.66B
| $568K | ﹤0.01% |
175,834
-1,757
| -1% | -$6.03K |
|
2580
HealthStream
HSTM
$840M
| $567K | ﹤0.01% |
20,917
+6
| +0% | +$150 |
|
|
CHS
2581
DELISTED
Chicos FAS, Inc.
CHS
| $566K | ﹤0.01% |
102,970
+32
| +0% | +$171 |
|
2582
AtaiBeckley Inc
ATAI
$2.68B
| $566K | ﹤0.01% |
312,723
+37
| +0% | +$63 |
|
2583
VanEck Pharmaceutical ETF
PPH
$938M
| $566K | ﹤0.01% |
7,290
| – | – |
|
2584
GoodRx Holdings
GDRX
$1.26B
| $565K | ﹤0.01% |
90,344
+9,252
| +11% | +$51.6K |
|
2585
Vanguard High Dividend Yield ETF
VYM
$82.8B
| $562K | ﹤0.01% |
5,330
+4,402
| +474% | +$473K |
|
|
NKLA
2586
DELISTED
Nikola Corporation Common Stock
NKLA
| $562K | ﹤0.01% |
15,487
+2,549
| +20% | +$167K |
|
2587
American Well
AMWL
$230M
| $562K | ﹤0.01% |
11,898
+642
| +6% | +$41.2K |
|
2588
Vanguard Real Estate ETF
VNQ
$39B
| $561K | ﹤0.01% |
6,750
-707
| -9% | -$60.7K |
|
|
TELL
2589
DELISTED
Tellurian Inc.
TELL
| $560K | ﹤0.01% |
454,973
+123
| +0% | +$196 |
|
2590
Genesco
GCO
$422M
| $556K | ﹤0.01% |
15,082
+76
| +0.5% | +$3.33K |
|
|
VERV
2591
DELISTED
Verve Therapeutics
VERV
| $556K | ﹤0.01% |
38,546
+1,841
| +5% | +$36K |
|
2592
Haverty Furniture Companies
HVT
$454M
| $555K | ﹤0.01% |
17,408
+2,218
| +15% | +$75.2K |
|
2593
FuboTV Inc
FUBO
$273M
| $553K | ﹤0.01% |
38,119
+8,040
| +27% | +$184K |
|
|
VTLE
2594
DELISTED
Vital Energy
VTLE
| $552K | ﹤0.01% |
12,114
+637
| +6% | +$31.8K |
|
2595
Sociedad Química y Minera de Chile
SQM
$20.6B
| $549K | ﹤0.01% |
6,768
+904
| +15% | +$77.8K |
|
2596
VanEck Agribusiness ETF
MOO
$969M
| $548K | ﹤0.01% |
6,314
+319
| +5% | +$28.2K |
|
2597
RE/MAX Holdings
RMAX
$242M
| $548K | ﹤0.01% |
29,226
+2,620
| +10% | +$52.2K |
|
2598
Mission Produce
AVO
$1.17B
| $546K | ﹤0.01% |
49,114
+1,773
| +4% | +$20.7K |
|
2599
Amplitude
AMPL
$1.41B
| $544K | ﹤0.01% |
43,755
+951
| +2% | +$12.6K |
|
2600
RCI Hospitality Holdings
RICK
$215M
| $544K | ﹤0.01% |
6,963
+2
| +0% | +$173 |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2023 Portfolio in Review
As of Q1 2023, Credit Suisse held 3,988 positions worth $99.2B, up 5.3% from $94.1B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $3.09B in Q1 2023, closing 658 positions and reducing 941 holdings. Its most notable exit was Cresud SACIF y A. Warrant, an estimated $59.2M position sold in full.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 21% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in GE HealthCare worth $34.2M.
- Credit Suisse's largest Q1 2023 buy was GE HealthCare: 417,250 shares worth $34.2M.
- Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q1 2023, an estimated $283M increase.
- Credit Suisse's biggest Q1 2023 reduction was Amazon, cutting an estimated $309M.
- Credit Suisse fully exited Cresud SACIF y A. Warrant in Q1 2023, selling an estimated $59.2M.
- Credit Suisse's ten largest holdings make up 20% of its $99.2B portfolio in Q1 2023.
- Credit Suisse opened 43 new positions and closed 658 in Q1 2023.
- Credit Suisse's portfolio value rose 5.3% quarter-over-quarter to $99.2B.
Based on Credit Suisse's 13F filing for Q1 2023, filed 10 May 2023.